Researchers discover new molecular driver of retinoblastoma

Despite decades of medical advances, children who develop the pediatric eye cancer retinoblastoma often lose their vision or an eye due to a lack of specific, targeted therapies and a poor molecular understanding of the cancer. Now researchers have discovered that a molecule -- estrogen-related receptor gamma, or ESRRG -- becomes hyperactive and promotes tumor cell survival in retinoblastoma. Blocking ESRRG, the team reported, kills retinoblastoma cells.

from Top Health News -- ScienceDaily https://ift.tt/NdlPEnI